2Bonnema SJ, Bennedbaek FN, Veje A, et al. Propylthiouracil before ^131I therapy of hyperthyroid diseases: effect on cure rate evaluated by a randomized clinical trial[J]. J Clin Endocrinol Metab, 2004,89 (9):4439-4444.
3Andrade VA, Gross JL, Maia AL. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves hyperthyroidism: one-year follow-up of a prospective, randomized study[J]. J Clin Endocrinol Metab, 2001,86 (8) :3488-3493.
4Higgins JPT,Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 0. 1 [updated September 2008]. The Cochrane Collaboration, 2008.
5Bazzi MN,Bagchi N. Adjunctive treatment with propylthiouracil or iodine following radioiodine therapy for Graves'disease [J]. Thyroid, 1993,3 (4) : 269-272.
6Kung AW, Yau CC,Cheng A. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole[J]. J Clinical endocrinol Metab, 1994,79(2) :542-546.
7Kung AW, Yau CC,Cheng AC. The action of methimazole and L-thyroxine in radioiodine therapy: a prospective study on the incidence of hypothyroidism[J]. Thyroid, 1995,5 ( 1 ) : 7-12.
8Bonnema SJ, Bennedbaek FN, Gram J, et al. Resumption of methimazole after ^131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clini cal trial[J]. Eur J Endocrinol,2003,149(6):485-923.
9Bonnema SJ, Bennedbaek FN, Veje A, et al. Continuous me thimazole therapy and its effect on the cure rate of hyperthy roidism using radioactive iodine: an evaluation by a randomized trial[J]. J Clin Endocrinol Metab, 2006,91 (8) : 2946-2951.
